Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892041 · ClinicalTrials.gov registry record
Diffusion MRI for Quantitative Assessment of Myofascial Pain
A clinical trial of Masticatory Myofascial Pain Syndrome, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 90
- Enrollment target
- 2
- Study locations
NCT06892041: Recruiting study of Masticatory Myofascial Pain Syndrome, sponsored by Weill Medical College of Cornell University.
NCT06892041 is a study of Masticatory Myofascial Pain Syndrome that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 90 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06892041, a study of Masticatory Myofascial Pain Syndrome, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the diagnostic accuracy of diffusion MRI for evaluation of the jaw muscles for patients with masticatory myofascial pain syndrome.
Conditions Studied
Study Locations (2)
New York
- New York University - New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-09-04 |
| Est. Completion | 2026-07 |
What NCT06892041 shows while recruiting
NCT06892041 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 1 condition, with Masticatory Myofascial Pain Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT06892041 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06892041 about?
NCT06892041 is a clinical study titled "Diffusion MRI for Quantitative Assessment of Myofascial Pain". The purpose of this study is to assess the diagnostic accuracy of diffusion MRI for evaluation of the jaw muscles for patients with masticatory myofascial pain syndrome.
What is the current status of trial NCT06892041?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2025-09-04. Estimated completion is 2026-07.
What conditions does trial NCT06892041 study?
This clinical trial studies the following conditions: Masticatory Myofascial Pain Syndrome.
Who is sponsoring clinical trial NCT06892041?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06892041 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI